Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 28, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Disease of Liver and Bile Duct
Interventions
PROCEDURE

vibration controlled transient elastography (VCTE)

Once on the examination table, the subject will be instructed to place the right arm under their head and to cross their right ankle over the left ankle. The subject will then be asked to slightly bend to the left side to open the intercostal space. Subsequently, a handheld probe is placed in the intercostal space overlaying the right hepatic lobe. The velocity of returning shear waves, measured at a depth of 25-65 mm, is converted into a liver stiffness measurement (LSM). The LSM obtained from a given VCTE exam is the median value of at least 10 successful measurements. This information, along with clinical data associated with the patient will be placed in a database for use in identifying potential subjects for future trials.

Trial Locations (1)

14203

RECRUITING

Conventus Medical Office Building, Buffalo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Kaleida Health

OTHER

lead

State University of New York at Buffalo

OTHER

NCT02897908 - Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database | Biotech Hunter | Biotech Hunter